Search
for
Sort by
Research 631–660 of 904
- The potential of androgenic alopecia management from plant derivatives
- Trichoscopic Findings of Frontal Fibrosing Alopecia
- Skin transcriptome reveals the Periodic changes in genes underlying hair follicle cycling in Cashmere goats
- Pharmacological Treatment of Alopecia
- Clinical Trials and Hair Loss
- Trichodystrophies: A hair-raising differential diagnosis
- An Update on Hair Restoration
- Acne scars: Classification and treatment
- A consensus-based treatment algorithm for alopecia areata in adolescents and adults: integrating severity, quality of life, and disease dynamics
- Topical latanoprost acid for female androgenetic alopecia: a pilot proof-of-concept trial with mechanistic evidence of prostaglandin F2α receptor activation
- Lipid nanocarriers as innovative strategies for hair regrowth
- People’s experiences of eyebrow transplantation: A qualitative study
- Aesthetic medicine treatments for oncology patients — a narrative literature review
- Clinical Perspectives on Alopecia: From Hair Follicle Biology to Advanced Therapies
- Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies
- Managing androgenic alopecia with individualised homeopathic medicine and biochemic remedies- An evidence based single case report
- Use of genetics in the prediction of success in male pattern hair loss therapy and mechanistic studies
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- A decade of progress in androgenetic alopecia management: Emerging therapies and multimodal strategies
- Alopesi Tedavisinde Kullanılan İlaç Tedavileri ve Yeni Yaklaşımlar
- Baricitinib Provides Higher Efficacy in Adolescents Relative to Adults With Alopecia Areata Despite More Severe Disease at Baseline: 36-Week Outcomes From BRAVE-AA Trials
- Case Series and Literature Review on Tofacitinib for Treating Severe Alopecia Areata
- Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata
- Role of microneedling in treatment of alopecia areata
- Patient Validation of Estimation of Health Utility Values in Alopecia Areata
- Prediction of Long-term Scalp Hair Regrowth at 24 Months in Patients with Alopecia Areata Receiving Ritlecitinib Treatment in the ALLEGRO Clinical Trial Program
- Treatment of frontal fibrosing alopecia: literature review 2020-2025
- The evaluation of IL-4 VNTR intron 3 and TNF-α (rs1799964) gene polymorphisms in Egyptian patients with alopecia areata: a case–control study
- Hair Product Allergy: A Review of Epidemiology and Management
- Survey on Alopecia Areata Patients’ Reported Factors that Determine Severity of Alopecia Areata: A Nationwide Multicenter Study